These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 26033683)
1. p53 Modulates Notch Signaling in MCF-7 Breast Cancer Cells by Associating With the Notch Transcriptional Complex Via MAML1. Yun J; Espinoza I; Pannuti A; Romero D; Martinez L; Caskey M; Stanculescu A; Bocchetta M; Rizzo P; Band V; Band H; Kim HM; Park SK; Kang KW; Avantaggiati ML; Gomez CR; Golde T; Osborne B; Miele L J Cell Physiol; 2015 Dec; 230(12):3115-27. PubMed ID: 26033683 [TBL] [Abstract][Full Text] [Related]
2. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional mechanisms by the coregulator MAML1. Saint Just Ribeiro M; Wallberg AE Curr Protein Pept Sci; 2009 Dec; 10(6):570-6. PubMed ID: 19751190 [TBL] [Abstract][Full Text] [Related]
4. Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells. Hao L; Rizzo P; Osipo C; Pannuti A; Wyatt D; Cheung LW; Sonenshein G; Osborne BA; Miele L Oncogene; 2010 Jan; 29(2):201-13. PubMed ID: 19838210 [TBL] [Abstract][Full Text] [Related]
5. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines. Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of MAML1 inhibits proliferation and induces apoptosis of T-cell acute lymphoblastic leukemia cells through SP1-dependent inactivation of TRIM59. Cheng H; Chen L; Hu X; Qiu H; Xu X; Gao L; Tang G; Zhang W; Wang J; Yang J; Huang C J Cell Physiol; 2019 Apr; 234(4):5186-5195. PubMed ID: 30370525 [TBL] [Abstract][Full Text] [Related]
7. The notch regulator MAML1 interacts with p53 and functions as a coactivator. Zhao Y; Katzman RB; Delmolino LM; Bhat I; Zhang Y; Gurumurthy CB; Germaniuk-Kurowska A; Reddi HV; Solomon A; Zeng MS; Kung A; Ma H; Gao Q; Dimri G; Stanculescu A; Miele L; Wu L; Griffin JD; Wazer DE; Band H; Band V J Biol Chem; 2007 Apr; 282(16):11969-81. PubMed ID: 17317671 [TBL] [Abstract][Full Text] [Related]
8. Detrimental effects of Notch1 signaling activated by cadmium in renal proximal tubular epithelial cells. Fujiki K; Inamura H; Matsuoka M Cell Death Dis; 2014 Aug; 5(8):e1378. PubMed ID: 25118938 [TBL] [Abstract][Full Text] [Related]
9. BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers. Buckley NE; Nic An tSaoir CB; Blayney JK; Oram LC; Crawford NT; D'Costa ZC; Quinn JE; Kennedy RD; Harkin DP; Mullan PB Nucleic Acids Res; 2013 Oct; 41(18):8601-14. PubMed ID: 23863842 [TBL] [Abstract][Full Text] [Related]
10. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications. Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of miR-34c inhibits high glucose-induced apoptosis in podocytes by targeting Notch signaling pathways. Liu XD; Zhang LY; Zhu TC; Zhang RF; Wang SL; Bao Y Int J Clin Exp Pathol; 2015; 8(5):4525-34. PubMed ID: 26191142 [TBL] [Abstract][Full Text] [Related]
12. A study on Notch signaling in human breast cancer. Zang S; Ji Ch; Qu X; Dong X; Ma D; Ye J; Ma R; Dai J; Guo D Neoplasma; 2007; 54(4):304-10. PubMed ID: 17822320 [TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer. Cohen B; Shimizu M; Izrailit J; Ng NF; Buchman Y; Pan JG; Dering J; Reedijk M Breast Cancer Res Treat; 2010 Aug; 123(1):113-24. PubMed ID: 19915977 [TBL] [Abstract][Full Text] [Related]
14. miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells. Lee YM; Lee JY; Ho CC; Hong QS; Yu SL; Tzeng CR; Yang PC; Chen HW Breast Cancer Res; 2011; 13(6):R116. PubMed ID: 22113133 [TBL] [Abstract][Full Text] [Related]
15. High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer. Izrailit J; Berman HK; Datti A; Wrana JL; Reedijk M Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1714-9. PubMed ID: 23319603 [TBL] [Abstract][Full Text] [Related]
16. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor. Raghu H; Gondi CS; Dinh DH; Gujrati M; Rao JS Mol Cancer; 2011 Oct; 10():130. PubMed ID: 22004682 [TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator uPA is a direct transcriptional target of the JAG1-Notch receptor signaling pathway in breast cancer. Shimizu M; Cohen B; Goldvasser P; Berman H; Virtanen C; Reedijk M Cancer Res; 2011 Jan; 71(1):277-86. PubMed ID: 21199807 [TBL] [Abstract][Full Text] [Related]
20. Regulation of p53 by jagged1 contributes to angiotensin II-induced impairment of myocardial angiogenesis. Guan A; Gong H; Ye Y; Jia J; Zhang G; Li B; Yang C; Qian S; Sun A; Chen R; Ge J; Zou Y PLoS One; 2013; 8(10):e76529. PubMed ID: 24098521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]